drugset / Trial / NCT03460041

Caudal Dexmetedomedine Versus Magnesium in Orthopedic Pediatric Surgeries

NCT03460041

RandomizedParallel-groupTriple-blindPrevention

Summary

This study will be performed in Abo Elreesh Pediatric Hospital / Cairo University after obtaining approval by the University Ethics Committee, and a written informed consent from the parents or guardians. Thirty six patients will be randomly assigned using an online randomization program (http://www.randomizer.org) and the sealed envelope method into three groups: Group D (n=12): Dexmetedomidine group. 0.5 ml of dexmetedomidine (2 μg/kg) added to bupivacaine, Group M (n=12) : Magnesium group.0.5 ml of magnesium sulphate (50 mg) added to bupivacaine, Group C (n=12) :Control group.bupivacaine 0.25% diluted in normal saline with total volume of 1 ml/kg.

Timeline

Start
2017-12-01
Primary completion
2018-03-15
Completion
2018-03-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmetedomedine Unknown 2 ug/kg Other
Comparator Magnesium Sulfate Other / unclassified 50 mg Other
Comparator Bupivacaine Other / unclassified 0.25 % Other

Indications

No indication recorded.